1
Maintenance Notice (12:30 AM - 5:30 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Merci de sélectionner la quantité
RET Kinase Inhibitor: RPI 1
RPI 1 (1) is a cell permeable ret/ptc1 kinase inhibitor and selectively inhibits the anchorage-independent growth of NIH3T3 transformants expressing the ret/ptc1 gene (NIH3T3ptc1 cells) (IC50 = 0.97 μM).1) By the tyrosine kinase assay using epidermal growth factor receptor as a target, it has been demonstrated that the inhibitory manner is ATP-competitive. 1 also inhibits hepatocyte growth factor-induced Met tyrosine phosphorylation (Tyr1234/Tyr1235) dose-dependently.2)
ret/ptc kinase: Rearranged in transformation/papillary thyroid carcinomas kinase
MET: mesenchymal–epithelial transition factorThis product is for research purpose only.
ret/ptc kinase: Rearranged in transformation/papillary thyroid carcinomas kinase
MET: mesenchymal–epithelial transition factor
References
- 1)Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative
- 2)Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.